Transcript
Page 1: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Genetics & Ethics

Philosophy 2803Lecture X

April 9, 2002

Page 2: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Introduction Tonight’s class will sketch some ethical

issues raised by genetics

Focus will be on genetic testing since this is currently available

There are many other ways in which genetics raises ethical issues, e.g., genetic engineering, gene therapy

Page 3: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Three Main Reasons Why Genetics is Ethically Interesting1. Genetic information often identifies risks of medical

conditions that don’t yet affect the patient– The ‘at risk’ patient

2. Genetic information is about families as well as individuals– As such, it sometimes doesn’t fit well into our usual

individualistic ways of thinking about consent, confidentiality, etc.

3. Genetic research is commercially driven to a very substantial degree– This raises questions about whether it is legitimate to allow

genes to be ‘owned’ and what people should expect in return for participating in genetic research

Page 4: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Case Study: Huntington’s Disease

A disease which causes deterioration of nerve cells in the brain

Slowly destroys the affected individual's ability to walk, think, swallow, talk, …

Normally begins affecting people when they are between 30 and 50 years old

Death (due to pneumonia, heart failure or other complications) usually occurs between 10 and 25 years after symptoms first appear

Page 5: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Genetics for Philosophers

Our chromosomes (which contain our genes) come in pairs.

We inherit one chromosome from each pair from each of our parents

The paired chromosomes, while similar, are not identical

About 1 in 10,000 people are thought to carry a mutation linked to Huntington’s Disease

Page 6: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Inheriting Huntington’s

Huntington’s is an example of a dominant genetic condition

– i.e., you only need to inherit one copy of a gene for Huntington’s in order to be almost certain to contract the condition at some point

If one of your parents carries a mutation linked to Huntington’s, you have a 50% chance of having inherited such a gene yourself.

Page 7: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Testing for Huntington’s

Huntington’s is caused by having an enlarged gene on chromosome 4

Since the early 90’s a very reliable genetic test for such an enlargement has existed

Even if you presently show no signs of Huntington’s, it can tell you with great reliability whether you carry a gene that makes it extraordinarily likely that you will develop Huntington’s.

There is no cure

Page 8: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Groupwork

1. If you carry a gene linked to Huntington’s, any children you have will be at a 50% risk of carrying the same gene

– Some, including Purdy (pp. 490-499), suggest this may make it immoral for you to attempt to have children

– Is this correct?

2. Suppose you knew that Huntington’s was in your family. Would you want to be tested for it?

Page 9: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Assessing Purdy’s Argument

“if it is true that sufferers [from Huntington’s] live substantially worse lives than do normal persons, those who might transmit it should not have children.” (496)

Response: this is a pretty big ‘if’

– It seems to require making judgments about what sort of live is worth living that are deeply troubling

Nonetheless, thinking about this issue should allow you to appreciate why genetics raises some distinct ethical questions.

Page 10: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Some Issues Raised by Genetic Testing

1. Risks of being tested

2. Problems posed by public conceptions of genetics

3. Problems with confidentiality & consent

4. ‘Commodifying’ our genes

Page 11: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

1. Risks of Being Tested Psychological

– If positive for a ‘bad’ mutation: Burden of knowing you have the predisposition,

particularly if no treatment is available Genetic determinism: possible overestimation of

likelihood of actually becoming afflicted – The situation with Huntington’s is not typical

– If negative: Evidence of ‘survivor guilt’ in some cases Possible over-confidence

– E.g., thinking you won’t get breast cancer because your test for BRCA1 & 2 came out OK

Page 12: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

More Risks of Being Tested Practical

– Employment– Life insurance– Health Insurance (more important in US)

Is it fair for companies to take genetic information into account when making hiring decisions or decisions about whether to insure a person?

Do these risks justify being paternalistic regarding who is given a genetic test, as DeGrazia suggests (pp. 474-490)?– ‘Traditionally,’ tests have not been given without genetic

counselling, although this is likely to change.– Recall the Rule of Justified Paternalism

Page 13: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

2. Popular Beliefs about Genetics

Genetic Determinism: The common misconception that all genes work like the gene for Huntington’s, i.e., the idea that having a particular gene will guarantee having a particular trait

– Huntington’s is an atypical example

– For the most part, having a particular gene mutation will just increase your chance of developing some trait, not guarantee it.

– Furthermore, most ‘genetic conditions’ are the result of a number of different gene mutations (as well as interactions with the environment)

We are unlikely to discover ‘the gene makes you good at math’

Page 14: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

3. Confidentiality & Consent

In medical ethics, a great deal of importance is placed on the idea of individual informed consent

– One aspect of this is that your personal health information is not supposed to be released without your consent

– But the nature of genetic information sometimes gets in the way of this

– Finding out genetic information about you also reveals genetic information about the people you’re related to

Page 15: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Case: Confidentiality & Huntington’s

Suppose there is a known history of Huntington’s in your family, but you don’t want to know whether you personally carry a mutation for Huntington’s.

Your son does, however. He gets tested and discovers that he has a mutation for Huntington’s.

This almost guarantees that you also carry such a mutation.

We have discovered personal information about you without your consent

– How should we deal with this? – Should we put restrictions on who your son can reveal this

information to?

Page 16: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Confidentiality & Duty to Warn

Most ethicists agree that, while confidentiality is important, there are situations in which confidentiality can be broken

The most common example involves a duty to warn

– E.g., a psychiatrist who is told by one of his patients that the patient plans to kill his wife tomorrow

Is there a genetic duty to warn?

– Must we warn family members who are at risk?– Should we warn employers if a person possesses a genetic

mutation that may someday pose a threat? E.g., the bus driver at high genetic risk of heart failure

Page 17: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Case Study: BRCA 1 & 2

About 5-10% of breast cancer is thought to be hereditary

It has been discovered that those women with particular mutations in the BRCA 1 or 2 gene are at an elevated risk of contracting breast cancer

– Without these mutations: 2% by age 50, 7% by age 70

– With the mutations: 33-50% by age 50, 56-87% by age 70

– Note: information is from Myriad Genetics’ website

Page 18: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Myriad Genetics & BRCA

Myriad Genetics (Utah, USA) holds patents on BRCA 1 & 2

They have recently been insisting that only they (or companies they have a licensing agreement with) may perform testing for the BRCA 1 & 2 mutations.

The government of Ontario has refused to obey, preferring to perform its own test, which it claims is both cheaper and more accurate

Page 19: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

4. Commodifying Genes

The Myriad example raises a number of questions regarding the commercialization of genetic research

– Is gene patenting ethically acceptable?– If our genes are a valuable commercial

resource, should we be paid for them?– Are genes property or person?

Page 20: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Newfoundland & Labrador

Questions about commercial research are particularly relevant in Newfoundland and Labrador

Most of the present population of the province can trace their ancestry back to settlers in the 1800s or earlier

– Some argue that Newfoundland has a ‘homogeneous’ gene pool that is very valuable for genetic research

– We have an elevated rate of some genetically influenced conditions (e.g., psoriasis)

For these reasons, Newfoundland had been described as "something of a motherlode to the drug development industry" (National Post, 2000).

Page 21: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

Should You Be Paid for Your DNA?

There has been some local debate about whether individuals should be paid for providing their DNA to researchers

– One former professor at MUN suggested $50,000 (US) per donation

Page 22: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

A Recent Report Policy Implications of Commercial Human Genetic

Research in Newfoundland and Labrador – Pullman & Latus, 2003

Argues that human DNA should be viewed as neither property nor person, but something in between

– Payments may sometimes be OK, but not individual ones.– In keeping with our general approach to health care as a

public good, payment should go to improve health care & research

– Gene patenting should be reconsidered

This by no means settles the issue

Page 23: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

So what was the point of all this?

Genetics provides a good final example for this course

– New developments in health care almost invariably raises new ethical problems

– New developments often cast old problems in new light

– Health ethics will never run out of problems

Page 24: Genetics & Ethics Philosophy 2803 Lecture X April 9, 2002

But …

‘All you’ve done is raise questions and problems. What was the point of that?’

Answer #1: Sometimes these problems don’t have clear solutions.– Sometimes making people sensitive to problems is the best

solution we can hope for– E.g., while we may not be able to stop a genetic test on

Mary’s son from revealing information about Mary, but by being aware we can at least try to minimize this problem

Answer #2: Ethics is hard– Progress does occur, but it’s very slow because these are

difficult problems. – The least we can do is subject these issues to a serious

public debate.


Top Related